Cargando…

Brain parenchymal and leptomeningeal metastasis in non-small cell lung cancer

Patients with advanced non-small cell lung cancer (NSCLC) are prone to brain metastases (BM), which essentially include brain parenchymal metastases (PM) and leptomeningeal metastases (LM). We conducted a retrospective study to comprehensively assess the clinical characteristics and risk factors of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Qing, Lin, Zhen, Hong, Ye, Fu, Yang, Chen, Yueyun, Liu, Ting, Zheng, Yue, Tian, Jiangfang, Liu, Chunhua, Pu, Wei, Ding, Zhenyu, Wang, Chun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9792549/ https://www.ncbi.nlm.nih.gov/pubmed/36572759 http://dx.doi.org/10.1038/s41598-022-26131-z

Ejemplares similares

Systematic Immunological Level Determined the Prognosis of Leptomeningeal Metastasis in Lung Cancer
por: Hong, Ye, et al.
Publicado: (2022)

Dramatic response to neoadjuvant savolitinib in marginally resectable lung adenocarcinoma with MET exon 14 skipping mutation: A case report and literature review
por: Tian, Jiangfang, et al.
Publicado: (2022)

Parenchymal Infiltration in Primary Diffuse Leptomeningeal Gliomatosis: Dynamic Changes in Brain MRI
por: Jiang, Yun, et al.
Publicado: (2017)

Incidence and Risk Factors for Leptomeningeal Carcinomatosis in Breast Cancer Patients with Parenchymal Brain Metastases
por: Jung, Jong-myung, et al.
Publicado: (2012)

Increased coexpression of PD-L1 and TIM3/TIGIT is associated with poor overall survival of patients with esophageal squamous cell carcinoma
por: Wang, Peipei, et al.
Publicado: (2021)

Diagnostic Value of CYFRA 21-1 in the Cerebrospinal Fluid for Leptomeningeal Metastasis
por: Zhang, Zhen, et al.
Publicado: (2017)

Poor Efficacy of Immune Checkpoint Inhibitors Plus Chemotherapy in Lung Cancer Patients with EGFR/ERBB2 Exon 20 Insertion
por: Zheng, Yue, et al.
Publicado: (2023)

Successful therapy using high-dose furmonertinib for non-small cell lung cancer with leptomeningeal metastasis: a case report and literature review
por: Chen, Ting, et al.
Publicado: (2023)

Hemidystonia as an Initial Manifestation of Leptomeningeal Metastasis
por: Jung, Hyun-Jung, et al.
Publicado: (2009)

The Riddle of the Sphinx: Progress in Leptomeningeal Metastasis of Non–Small Cell Lung Cancer
por: Zhao, Yuhua, et al.
Publicado: (2023)

Nomogram Personalizes and Visualizes the Overall Survival of Patients with Triple-Negative Breast Cancer Based on the Immune Genome
por: Wang, Peipei, et al.
Publicado: (2020)

NEIM-01 INCIDENCE AND DIAGNOSTIC TECHNIQUES FOR LEPTOMENINGEAL DISEASE IN PATIENTS WITH BRAIN METASTASIS
por: Henry, Katie, et al.
Publicado: (2022)

Novel method for the detection and quantification of malignant cells in the CSF of patients with leptomeningeal metastasis of lung cancer
por: MA, CHUNHUA, et al.
Publicado: (2016)

Leptomeningeal Metastasis: The Role of Cerebrospinal Fluid Diagnostics
por: Bönig, Lena, et al.
Publicado: (2019)

Brain metastasis and intracranial leptomeningeal metastasis from malignant peripheral nerve sheath tumors: illustrative cases
por: Ohno, Masasuke, et al.
Publicado: (2023)

Leptomeningeal metastasis from solid tumors: clinical features and its diagnostic implication
por: Pan, Zhenyu, et al.
Publicado: (2018)

Genotyping of cerebrospinal fluid in lung cancer patients with leptomeningeal metastasis
por: Nie, Naifu, et al.
Publicado: (2022)

Whole brain radiotherapy (WBRT) for leptomeningeal metastasis from NSCLC in the era of targeted therapy: a retrospective study
por: Zhen, Junjie, et al.
Publicado: (2020)

Leptomeningeal metastasis from hepatocellular carcinoma with other unusual metastases: a case report
por: Pan, Zhenyu, et al.
Publicado: (2014)

Identification of Cerebrospinal Fluid MicroRNAs Associated With Leptomeningeal Metastasis From Lung Adenocarcinoma
por: Pan, Zhenyu, et al.
Publicado: (2020)

Breast cancer leptomeningeal metastasis: propensity of breast cancer subtypes for leptomeninges and the analysis of factors influencing survival
por: Niwińska, Anna, et al.
Publicado: (2013)

Leptomeningeal enhancement in magnetic resonance imaging predicts poor prognosis in lung adenocarcinoma patients with leptomeningeal metastasis
por: Gao, Xiaoxing, et al.
Publicado: (2022)

Inferior outcome of bone metastasis in non-small-cell-lung-cancer patients treated with epidermal growth factor receptor inhibitors
por: Chen, Yue-Yun, et al.
Publicado: (2021)

Potential benefit of osismertinib plus bevacizumab in leptomeningeal metastasis with EGFR mutant non-small-cell lung cancer
por: Yi, Yali, et al.
Publicado: (2022)

Prognostic significance of molecular characteristics of cerebrospinal fluid for non‐small cell lung cancer patients with leptomeningeal metastasis
por: Li, Ning, et al.
Publicado: (2019)

Leptomeningeal metastasis in breast cancer – a systematic review
por: Scott, Brian J., et al.
Publicado: (2015)

A case report of prostate cancer with leptomeningeal metastasis
por: Dehghani, Mansoureh, et al.
Publicado: (2021)

Hemangioblastoma with late leptomeningeal metastasis: a case report
por: Poiset, Spencer J., et al.
Publicado: (2023)

A Rare Case of Metastasis of Gastric Adenocarcinoma to the Leptomeninges
por: Doshi, Krishna, et al.
Publicado: (2023)

Leptomeningeal Metastasis in Gliomas : Clinical Characteristics and Risk Factors
por: Yang, Jeyul, et al.
Publicado: (2023)

Survival Outcomes of Patients With Epidermal Growth Factor Receptor Mutations in Non-Small Cell Lung Cancer With Leptomeningeal Metastasis
por: Li, Ning, et al.
Publicado: (2022)

Whole brain radiation therapy does not improve the overall survival of EGFR-mutant NSCLC patients with leptomeningeal metastasis
por: Yan, Weiwei, et al.
Publicado: (2019)

LPTO-07. CARCINOEMBRYONIC ANTIGEN OF CEREBROSPINAL FLUID PREDICT PROGNOSIS OF LEPTOMENINGEAL METASTASIS FROM NON-SMALL CELL LUNG CANCER
por: Zhen, Junjie, et al.
Publicado: (2019)

CEACAM6 serves as a biomarker for leptomeningeal metastasis in lung adenocarcinoma
por: Wang, Xueying, et al.
Publicado: (2022)

Correction: Potential benefit of osimertinib plus bevacizumab in leptomeningeal metastasis with EGFR mutant non-small-cell lung cancer
por: Yi, Yali, et al.
Publicado: (2022)

Cerebrospinal fluid metabolomic profiles can discriminate patients with leptomeningeal carcinomatosis from patients at high risk for leptomeningeal metastasis
por: Yoo, Byong Chul, et al.
Publicado: (2017)

Leptomeningeal carcinomatosis in small cell carcinoma of the prostate
por: Fukuta, Kyotaro, et al.
Publicado: (2022)

21. A PHASE II TRIAL OF COMPREHENSIVE TREATMENT BASED ON RADIOTHERAPY IN LEPTOMENINGEAL METASTASIS
por: Yang, Siran, et al.
Publicado: (2020)

Glioblastoma Multiforme in the Pineal Region with Leptomeningeal Dissemination and Lumbar Metastasis
por: Matsuda, Ryosuke, et al.
Publicado: (2015)

41. PROGNOSTIC VALIDATION OF THE EANO ESMO CLASSIFICATION OF LEPTOMENINGEAL METASTASIS
por: Le Rhun, Emilie, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_uabtrqgpgc7spm969qesnr0qjr